PILSICAINIDE for Atrial fibrillation: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 18 adverse event reports in the FDA FAERS database where PILSICAINIDE was used for Atrial fibrillation.
Most Reported Side Effects for PILSICAINIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Bradycardia | 11 | 13.1% | 0 | 7 |
| Atrial fibrillation | 8 | 9.5% | 0 | 7 |
| Renal impairment | 8 | 9.5% | 0 | 8 |
| Dizziness | 7 | 8.3% | 0 | 5 |
| Electrocardiogram qt prolonged | 7 | 8.3% | 0 | 4 |
| Toxicity to various agents | 6 | 7.1% | 2 | 5 |
| Blood pressure decreased | 5 | 6.0% | 0 | 4 |
| Cardiac failure | 5 | 6.0% | 1 | 2 |
| Decreased appetite | 5 | 6.0% | 0 | 5 |
| Depressed level of consciousness | 5 | 6.0% | 0 | 5 |
| Drug interaction | 5 | 6.0% | 1 | 0 |
| Hyperkalaemia | 5 | 6.0% | 0 | 5 |
| Off label use | 5 | 6.0% | 0 | 4 |
Other Indications for PILSICAINIDE
Other Drugs Used for Atrial fibrillation
RIVAROXABAN (52,584)
DABIGATRAN ETEXILATE (20,492)
APIXABAN (10,500)
AMIODARONE (9,083)
WARFARIN (8,680)
EDOXABAN (3,855)
ASPIRIN (2,993)
DOFETILIDE (2,439)
PRADAXA (2,325)
METOPROLOL (1,542)